Term
|
Definition
|
|
Term
|
Definition
| 2.5-3 mg in 2.5-3 ml normal saline nebulized |
|
|
Term
|
Definition
| Bronchodialator, Sympathomimetic |
|
|
Term
|
Definition
| C.O.P.D, Asthma, Pnuemonia, Asthma |
|
|
Term
| Albuterol Contraindications |
|
Definition
| Known hypersensitivity to the drug |
|
|
Term
|
Definition
CNS: Tremors, Anxiety, Dizziness, Seizures, Headaches, Insomnia
G.I.: Nausea, Dyspepsia
EENT: Pharyngitis, nasal congestion,
CV: Palpatations, Tach, Hypertension
Respiratory: Bronchiospasm, Cough, Wheezing |
|
|
Term
|
Definition
|
|
Term
|
Definition
0.5 MG in 2.5-3 ML Nebulized
PEDI Dose: 1.25 MG-2.5 MG in 2.5-3 ML Nebulized |
|
|
Term
| Atrovent Contraindications |
|
Definition
Hypersensitivity to Atropine or it's derivatives.
Should not be used as a primary treatment of acute episode of bronchiospasm.
Caution use in pregnancy and nursing mothers. |
|
|
Term
|
Definition
Parasympatholytic
Bronchiodialator |
|
|
Term
|
Definition
EENT: Blurred Vision, Acute eye pain, worsening of narrow angle glaucoma.
GI: Bitter taste, Dry oropharyngeal membrane, with higher doses nausea, constipation.
Respiratory: Cough, hoarseness, exacerbation of symptoms, drying of brochiole secretions, ulcers, nose bleeds, nasal dryness
Other: Rash, hives, urinary retention, headache |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 200 MG 1 Second spray to the throat |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Patient cannot maintain their own patent airway, must be done by another. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
0.1-0.3 MG/KG IV push over 15-30 Secs
PEDI: Do Not use on patients younger than 10. Patients 10 or older same dose. |
|
|
Term
|
Definition
|
|
Term
| Etomidate Contraindications |
|
Definition
| Patients with hypersensitivity to the drug, patients with marked hypotension, severe asthma, or severe cv disease. Safety in children younger than 10 has not been established. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
40-120 MG slow IV push or, twice their daily dose up to 120 MG.
PEDI: 1 MG/KG slow IV push. |
|
|
Term
|
Definition
| Hypotension, increases toxicity of digoxin because of hypokalemia, non polarizing nueromuscular blocking agent, polyuria. |
|
|
Term
| Furosemide Contraindications |
|
Definition
| Increasing oliguria, anuria, fluid and electrolyte depletion states; hepatic coma; pregnancy (category c). Use with caution in infants, elderly patients; hepatic cirrhosis, nephrotic syndrome; cardiogenic shock associated with acute MI, history of gout; patients recieving digitalis glycosides or potassium-depleting steroids. |
|
|
Term
|
Definition
|
|
Term
| Magnesium Sulfate Trade Name |
|
Definition
|
|
Term
|
Definition
| Reverses refractory ventricular fibrillation and pulseless ventricular tach. |
|
|
Term
|
Definition
Adult Dose: 1-2 G IV over 1-2 Mins.
PEDI Dose: 25-50 MG/KG IV/IM
To Reverse torsades de pointes: (Adult): 1-2 G IV followed by infusion of 0.5-1.0 G/HR IV. PEDI: SAME
To provide prophylaxis following acute myocardial infarction: 1-2 G IV over 5-30 mins. Children don't usually have MI's.
To Manage seizures caused by ecalmpsia: 2-4 G IV/IM |
|
|
